Morphological effects of an antitumor agent on human esophageal carcinoma cells in vitro.
D002277:Carcinoma / Q000188:drug therapy* / Q000648:ultrastructure; D002460:Cell Line; D002462:Cell Membrane / Q000648:ultrastructure*; D004353:Drug Evaluation, Preclinical; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000648:ultrastructure; D006801:Humans; D008244:Lysophosphatidylcholines / Q000627:therapeutic use*; D008563:Membrane Lipids / Q000378:metabolism; D008871:Microvilli / Q000648:ultrastructure*; D008938:Mitosis / Q000187:drug effects; D010742:Phospholipid Ethers; D010743:Phospholipids / Q000378:metabolism
D008244:Lysophosphatidylcholines; D008563:Membrane Lipids; D010742:Phospholipid Ethers; D010743:Phospholipids; C026659:edelfosine